Bank of America
CYCN icon

Bank of America’s Cyclerion Therapeutics CYCN Stock Holding History

Bank of America’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-107
Closed -$136 – 6003
2025
Q4 		$136 Buy
107
+85
+386% +$152 ﹤0.01% 6766
2025
Q3 		$50 Sell
22
-2
-8% -$5 ﹤0.01% 8007
2025
Q2 		$70 Buy
24
+5
+26% +$15 ﹤0.01% 8037
2025
Q1 		$48 Hold
19
– – ﹤0.01% 7990
2024
Q4 		$62 Sell
19
-4
-17% -$11 ﹤0.01% 7831
2024
Q3 		$59 Buy
23
+7
+44% +$21 ﹤0.01% 7812
2024
Q2 		$37 Buy
+16
New +$45 ﹤0.01% 7899
2023
Q1 		– Sell
-2
Closed -$31 – 7883
2022
Q4 		$31 Buy
+2
New +$24 ﹤0.01% 7895
2022
Q3 		– Sell
-1
Closed -$17 – 7897
2022
Q2 		$0 Sell
1
-123
-99% -$1.76K ﹤0.01% 8077
2022
Q1 		$3K Buy
124
+101
+439% +$2.43K ﹤0.01% 7973
2021
Q4 		$1K Sell
23
-3
-12% -$142 ﹤0.01% 8046
2021
Q3 		$2K Sell
26
-275
-91% -$18K ﹤0.01% 7876
2021
Q2 		$23K Sell
301
-1,324
-81% -$82.9K ﹤0.01% 7093
2021
Q1 		$90K Buy
1,625
+833
+105% +$62.6K ﹤0.01% 6436
2020
Q4 		$48K Buy
792
+288
+57% +$19.6K ﹤0.01% 6341
2020
Q3 		$61K Sell
504
-278
-36% -$31.8K ﹤0.01% 5935
2020
Q2 		$93K Buy
782
+250
+47% +$20.9K ﹤0.01% 5706
2020
Q1 		$28K Sell
532
-97
-15% -$6.92K ﹤0.01% 6062
2019
Q4 		$34K Sell
629
-345
-35% -$32.2K ﹤0.01% 6366
2019
Q3 		$236K Sell
974
-652
-40% -$141K ﹤0.01% 5560
2019
Q2 		$372K Buy
+1,626
New +$460K ﹤0.01% 5261

Other funds holding CYCN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America's CYCN Position: Q1 2026 in Review

Bank of America sold out of Cyclerion Therapeutics (CYCN) in Q1 2026, closing a stake of 107 shares — an estimated $136 sold.

Bank of America first reported a position in CYCN in Q2 2019 and held it in 21 quarters. The position peaked at $372K in Q2 2019. 17 funds tracked by Wall St. Rank hold CYCN as of Q1 2026.

  • Bank of America reported no remaining Cyclerion Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 107 Cyclerion Therapeutics shares in Q1 2026, an estimated $136.
  • Bank of America first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 21 quarters.
  • Bank of America's Cyclerion Therapeutics position peaked at $372K in Q2 2019.
  • 17 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.